From: Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
Database | Date | Keyword A | Keyword B | N |
---|---|---|---|---|
Web of Sciences | 08.06.2021 | PFAS | immune*, TDAR*, TIAR*, TIAR*, SRBC*, IgG*, IgE*, Host infection studies, viral infection, bacterial infection, innate immunity, hypersensitivity, B-cell function, plasma cell function, lymphotoxicity, Lym*, thymus atrophy, thymu*, spleen atrophy, spleen*, thymus cellularity, spleen cellularity, PPAR* | 88 |
Web of Sciences | 09.06.2021 | PFAS | natural killer cell, cytokine*, IL-1R1*, IL-1Ra*, interleukin*, NF-kB*, macrophage*, mast cells, histamine*, hexosaminidase*, IFN-gamma*, T-cell, reactive oxygen species, mitochondria*, apoptosis*, host infection, inflammasome*, Nrf-2*, Nrf2*, NFAT*, calci*, neopterin*, tryptophan*, glucocorticoid*, JAK3*, p53*, Bax*, superoxiddismutase*, superoxid*, glutathion*, GST*, lipid peroxidation, caspase*, BcL-2*, BcL2*, fatty acid metabolism, innate immunity, hypersensitivity, asthma*, allerg*, respiratory infection, autoimmunity | 185 |
Web of Sciences | 23.06.2021 | perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | TDAR*, TIAR*, SRBC*, KLH*, HRBC*, “host infection”, T-cell, infect*, | 3 |
PubMed | 10.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | immune, TDAR, T-cell, TIAR, SRBC, IgG, IgE, “host infection”, “viral infection”, “bacterial infection”, “innate immunity”, hypersensitivity | 192 |
PubMed | 11.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | B-cell, “plasma cell function”, lymphotoxicity, “thymus atrophy”, “spleen atrophy”, “thymus cellularity”, “spleen cellularity”, PPAR, “natural killer”, cytokines | 192 |
PubMed | 12.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | cytokines, interleukin, NF-kB, macrophage, “mast cells”, histamine, hexosaminidase, IFN-gamma, | 108 |
PubMed | 13.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | “reactive oxygen species”, mitochondria, apoptosis, inflammasome, Nrf-2, Nrf2, NFAT, calcium, neopterin, tryptophan, “glucocorticoid receptor”, JAK3, p53, Bax, “superoxid dismutase”, glutathione, “GSH-transferase”, GST, | 187 |
PubMed | 14.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | Inflammasome, Nrf-2, Nrf2, NFAT, calcium, neopterin, tryptophan, “glucocorticoid receptor”, JAK3, p53, Bax, “superoxid dismutase”, “glutathione”, “GSH-transferase”, GST, | 191 |
PubMed | 15.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | “lipid peroxidation”, caspase | 41 |
PubMed | 17.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | BcL-2, BcL2, “fatty acid metabolism”, “innate immunity”, hypersensitivity, asthma | 116 |
PubMed | 18.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | asthma, allergies, “respiratory infection”, autoimmunity, | 160 |
PubMed | 20.06.2021 | PFAS, perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | infection | 141 |
Scopus | 08/09.07.2021 | perfluor*, polyfluor*, PFBS*, PFHxS*, PFOS*, PFBA*, PFHxA*, PFOA*, PFNA*, PFDA*, PFUnDA*, PFDoDA*, HFPO-DA*, GenX* | immune*, TDAR*, TIAR*, SRBC*, KLH*, HRBC*, PPAR*, infect*, T-cell*, antibod* | 80 |